Go Deep
Pfizer Inc.
Pfizer Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,166 | 36.6 | 1.86 | 0.74 | 2,674.00 |
| Oct 2026 | 19,166 | 36.6 | 1.86 | 0.74 | 2,673.72 |
| Oct 2026 | 19,166 | 36.6 | 1.86 | 0.74 | 2,673.72 |
| Oct 2026 | 19,247 | 36.1 | 1.83 | 0.74 | 2,636.21 |
| Oct 2026 | 19,478 | 36.2 | 1.84 | 0.74 | 2,651.50 |
| Oct 2026 | 19,478 | 36.2 | 1.84 | 0.74 | 2,651.50 |
| Oct 2026 | 19,375 | 36.8 | 1.87 | 0.74 | 2,703.00 |
| Oct 2026 | 19,412 | 36.6 | 1.86 | 0.74 | 2,685.63 |
| Oct 2026 | 19,067 | 37.2 | 1.89 | 0.74 | 2,736.27 |
| Oct 2026 | 19,042 | 37.4 | 1.90 | 0.74 | 2,719.03 |
| Oct 2026 | 19,419 | 37.3 | 1.90 | 0.74 | 2,701.78 |
| Oct 2026 | 19,294 | 38.4 | 1.95 | 0.74 | 2,773.42 |
| Oct 2026 | 19,313 | 37.7 | 1.97 | 0.74 | 2,795.65 |
| Oct 2026 | 19,283 | 38.9 | 1.98 | 0.74 | 2,801.67 |
| Oct 2026 | 19,312 | 38.7 | 1.97 | 0.74 | 2,791.39 |
| Oct 2026 | 19,238 | 39.6 | 2.02 | 0.74 | 2,854.92 |
| Oct 2026 | 19,290 | 39.3 | 2.00 | 0.74 | 2,823.28 |
| Oct 2026 | 19,207 | 40.0 | 2.04 | 0.74 | 2,871.37 |
Pfizer Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 15,034,000,000.0 | 14,450,000,000.0 | 17,557,000,000.0 | 16,654,000,000.0 |
| Net Profit | -248,000,000.0 | 2,687,000,000.0 | -1,648,000,000.0 | 3,541,000,000.0 |
| EPS | -0.0 | 0.5 | -0.3 | 0.6 |
Pfizer Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 62,579,000,000.0 | 63,627,000,000.0 | 59,554,000,000.0 | 101,175,000,000.0 | — |
| Net Profit | 7,771,000,000.0 | 8,031,000,000.0 | 2,119,000,000.0 | 31,372,000,000.0 | — |
| EPS | 1.4 | 1.4 | 0.4 | 5.6 | — |
Pfizer Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 208,160,000,000.0 | 213,396,000,000.0 | 226,501,000,000.0 | 197,205,000,000.0 | — |
| Total Liabilities | 121,385,000,000.0 | 124,899,000,000.0 | 137,213,000,000.0 | 101,289,000,000.0 | — |
| Total Equity | 86,476,000,000.0 | 88,203,000,000.0 | 89,014,000,000.0 | 95,661,000,000.0 | — |
Owes vs Owns
Pfizer Inc. owed $0.57 for every $1 it owned in Jun 2026, up from $0.51 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.57× | 0.58× | 0.59× | 0.61× | 0.51× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Pfizer Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 6.5%Receivables 7.6%Inventory 5.1%Fixed assets (tangible) 9.3%Intangible assets 60.0%Long-term investments 0.8%Other assets 10.6%
How it's funded — Dec 2025
Short-term debt 1.5%Long-term debt 29.2%Payables 2.5%Other liabilities 25.1%Shareholders' equity 41.7%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 13,596.0 | 20,477.0 | 12,690.0 | 22,732.0 |
| Receivables | 15,841.0 | 14,777.0 | 15,544.0 | 14,529.0 |
| Inventory | 10,654.0 | 10,851.0 | 10,189.0 | 8,981.0 |
| Fixed assets (tangible) | 19,317.0 | 18,393.0 | 18,940.0 | 16,274.0 |
| Intangible assets | 124,994.0 | 123,939.0 | 132,683.0 | 94,745.0 |
| Long-term investments | 1,622.0 | 2,227.0 | 15,368.0 | 15,069.0 |
| Other assets | 22,136.0 | 22,732.0 | 21,087.0 | 24,875.0 |
| Liabilities & equity | ||||
| Short-term debt | 3,154.0 | 6,946.0 | 10,346.0 | 2,934.0 |
| Long-term debt | 60,807.0 | 56,703.0 | 60,499.0 | 31,925.0 |
| Payables | 5,240.0 | 5,633.0 | 6,710.0 | 6,809.0 |
| Other liabilities | 52,184.0 | 55,617.0 | 59,658.0 | 59,621.0 |
| Shareholders' equity | 86,775.0 | 88,497.0 | 89,288.0 | 95,916.0 |
| Net tangible assets | -38,518.0 | -35,736.0 | -43,669.0 | 916.0 |
Pfizer Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 11,704,000,000.0 | 12,744,000,000.0 | 8,700,000,000.0 | 29,267,000,000.0 | — |
| Investing Activities | -1,351,000,000.0 | 2,652,000,000.0 | -32,278,000,000.0 | -15,783,000,000.0 | — |
| Financing Activities | -10,304,000,000.0 | -17,140,000,000.0 | 26,066,000,000.0 | -14,834,000,000.0 | — |